Allergy Therapeutics PLC
LSE:AGY
Allergy Therapeutics PLC
LSE:AGY
Price:
3.4 GBX
Market Closed
Updated:
May 22, 2024
Allergy Therapeutics PLC
Operating Expenses
|
Allergy Therapeutics PLC
Operating Expenses Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Operating Expenses
-£66.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Expenses
-£15.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Expenses
-$30.5B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-6%
|
|
|
Indivior PLC
LSE:INDV
|
Operating Expenses
-$674m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Expenses
-$785m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Operating Expenses
-£404.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-17%
|
See Also
What is Allergy Therapeutics PLC's Operating Expenses?
Operating Expenses
-66.8m
GBP
-66.8m
GBP
Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Operating Expenses amounts to -66.8m GBP.
What is Allergy Therapeutics PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-9%
-9%
Over the last year, the Operating Expenses growth was 0%. The average annual Operating Expenses growth rates for Allergy Therapeutics PLC have been -8% over the past three years , -3% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
